Carrying its quality management processes from manual to digital, Berko Pharmaceuticals continues to grow in sync with modern business life. Having completely digitized its quality management processes, Berko Pharmaceuticals once again emphasizes its innovative and uncompromising values by switching to Qmex software, which has been validated in accordance with 21 CFR Part 11 requirements.
Berko Pharmaceuticals, which has been working and producing for public health for more than thirty-five years with the motto of “Healthy Tomorrows”, has made an innovation in its quality management processes. Having completely digitized its quality management processes, Berko Pharmaceuticals has once again demonstrated its innovative vision that does not compromise on quality, with its Qmex software validated in accordance with the requirements of 21 CFR Part 11, where all information can be easily accessed by its employees.
With Qmex, electronic signature, module-based authorization, audit trail, record history, action-based scheduled notifications, personal page; such as pending jobs, delegated jobs, bookmarks, graphics and reports, tracking of trend reports, adding multiple files, related records screen, integration between modules, integration with all 3rd party software including ERPs, strong workflow management, company reputation. It is a Qmex software system, imed to benefit in many ways.
By switching to the Qmex software system, Berko Pharmaceuticals will be able to easily access all information on a single platform. Dr. Chem. Haluk Akkuş Quality Assurance Manager, Berko Pharmaceuticals, commented on the subject, “We crowned our innovative and forward-looking vision by migrating our business processes to Qmex. We are happy to be a part of the digital age in the business management processes we use in the company.”
